Amphotericin B-induced hepatorenal failure in cystic fibrosis

Pediatric Pulmonology

Volumn 33, Issue 6, 2002, Pages 497-500

  Mohan, Uthara R ^a   Bush, Andrew ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Amphotericin B; Aspergillus fumigatus; Cystic fibrosis; Pseudomonas aeruginosa

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CEFTAZIDIME; GENTAMICIN;

ADULT; ARTICLE; ASPERGILLOSIS; CASE REPORT; CLINICAL FEATURE; CYSTIC FIBROSIS; DISEASE COURSE; HEPATORENAL SYNDROME; HUMAN; LIVER TOXICITY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL;

AMEBICIDES; AMPHOTERICIN B; ASPERGILLOSIS; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; KIDNEY FAILURE; LIVER FAILURE;

EID: 0036099694     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10106     Document Type: Article

References (16)

1. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis
2. Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis
3. Fatal invasive aspergillosis in an adolescent with cystic fibrosis
4. A multicenter study of alternate day prednisolone therapy in patients with cystic fibrosis
5. Antimicrobial agents
6. Pharmacology, toxicity, and therapeutic usefulness of amphotericin B
7. Fatal toxic reaction to amphotericin B in cryptococcal meningo-encephalitis
8. Reversible hepatotoxicity related to amphotericin B
9. Hepatotoxicity possibly caused by amphotericin B
10. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
11. Antibiotic treatment of initial colonisation with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis
12. Clinical significance of the recovery of aspergillus species from the respiratory secretions of cystic fibrosis patients
13. 30 Years of clinical experience
14. Permeabilty concentration in animal cells by polyenes: A possibility
15. Reversal of cancer chemotherapeutic resistance by amphotericin B. A broad phase I-II pilot study
16. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B